PHARMACOLOGICAL PROPERTIES OF 403U76, A NEW CHEMICAL CLASS OF 5-HYDROXYTRYPTAMINE-REUPTAKE AND NORADRENALINE-REUPTAKE INHIBITOR

被引:38
作者
FERRIS, RM [1 ]
BRIEADDY, L [1 ]
MEHTA, N [1 ]
HOLLINGSWORTH, E [1 ]
RIGDON, G [1 ]
WANG, C [1 ]
SOROKO, F [1 ]
WASTILA, W [1 ]
COOPER, B [1 ]
机构
[1] WELLCOME RES LABS,ORGAN CHEM,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1111/j.2042-7158.1995.tb06740.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
403U76 (5-chloro-[[2-[(dimethylamino)methyl]phenyl]thio]benzene-methanol hydrochloride) is a potent, competitive, inhibitor of 5-hydroxytryptamine (5-HT) and noradenaline reuptake into rat brain synaptosomes. Inhibition of 5-HT uptake in-vivo by 403U76 was demonstrated by potentiation of the behavioural effects of 5-hydroxytryptophan in rats and mice and blockade of p-induced depletion of 5-HT in rats. The firing of 5-HT-ergic dorsal raphe neurons in rats was decreased after intravenous administration of low doses of 403U76 as would be predicted for a 5-HT uptake inhibitor. 403U76 antagonized tetrabenazine-induced sedation, an effect associated with inhibitors of noradrenaline uptake, but not with inhibitors of 5-HT uptake. Thus 403U76 affects noradrenergic as well as 5-HT-ergic neurotransmission in-vivo. Potential anxlolytic activity was indicated by reductions in isolation-induced vocalizations in neonates after 403U76 treatment. Low intravenous doses of 403U76 were well tolerated and had no sustained cardiovascular effects. There were no deleterious behavioural side-effects at active doses. Effects observed on isolated tissues or transmitter receptors occurred only at very high concentrations and were pharmacologically unimportant. Thus 403U76 can be considered a potential antidepressant/anxiolytic agent that is a potent, selective inhibitor of 5-HT and noradrenaline reuptake.
引用
收藏
页码:775 / 781
页数:7
相关论文
共 29 条
[1]   LYSERGIC-ACID DIETHYLAMIDE AND SEROTONIN - DIRECT ACTION ON SEROTONIN-CONTAINING NEURONS IN RAT-BRAIN [J].
AGHAJANIAN, GK ;
BLOOM, FE ;
HAIGLER, HJ .
LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1972, 11 (13) :615-+
[2]  
BUNNEY WE, 1975, PSYCHOPHARMACOL COMM, V1, P599
[3]  
BURNS RF, 1986, MOL PHARMACOL, V29, P331
[4]  
BURNS RF, 1980, P NATL ACAD SCI USA, V77, P5547
[5]   IDENTIFICATION OF LEUKOTRIENE-D4 RECEPTOR-BINDING SITES IN GUINEA-PIG LUNG HOMOGENATES USING [H-3]-LABELED LEUKOTRIENE-D4 [J].
CHENG, JB ;
TOWNLEY, RG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 118 (01) :20-26
[6]  
COPPEN A, 1967, BRIT J PSYCHIAT, V133, P1237
[7]   A METHOD FOR ASSESSING EFFECTS OF DRUGS ON CENTRAL ACTIONS OF 5-HYDROXYTRYPTAMINE [J].
CORNE, SJ ;
WARNER, BT ;
PICKERING, RW .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1963, 20 (01) :106-&
[8]   RIMCAZOLE (BW U-234), A NOVEL ANTIPSYCHOTIC AGENT WHOSE MECHANISM OF ACTION CANNOT BE EXPLAINED BY A DIRECT BLOCKADE OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS IN BRAIN [J].
FERRIS, RM ;
WHITE, HL ;
TANG, FLM ;
RUSSELL, A ;
HARFENIST, M .
DRUG DEVELOPMENT RESEARCH, 1986, 9 (03) :171-188
[10]   EVIDENCE THAT THE POTENTIAL ANTIPSYCHOTIC AGENT RIMCAZOLE (BW U-234) IS A SPECIFIC, COMPETITIVE ANTAGONIST OF SIGMA-SITES IN BRAIN [J].
FERRIS, RM ;
TANG, FLM ;
CHANG, KJ ;
RUSSELL, A .
LIFE SCIENCES, 1986, 38 (25) :2329-2337